| Comparative effectiveness of direct oral anticoagulants and warfarin for the treatment of left ventricular thrombus ME Bass, TH Kiser, RL Page, CK McIlvennan, LA Allen, G Wright, ... Journal of Thrombosis and Thrombolysis, 1-6, 2021 | 57 | 2021 |
| Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients MF Gaynor, GC Wright, S Vondracek Therapeutic advances in cardiovascular disease 12 (1), 7-15, 2018 | 22 | 2018 |
| Evaluation of prophylactic heparin dosage strategies and risk factors for venous thromboembolism in the critically ill patient PM Reynolds, ET Van Matre, GC Wright, RB McQueen, EL Burnham, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (3 …, 2019 | 21 | 2019 |
| Evaluation of unfractionated heparin versus low‐molecular‐weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer ET Van Matre, PM Reynolds, R MacLaren, SW Mueller, GC Wright, ... Journal of Thrombosis and Haemostasis 16 (12), 2492-2500, 2018 | 14 | 2018 |
| Association between vasopressin rebranding and utilization in patients with septic shock GL Sacha, TH Kiser, GC Wright, RW Vandivier, M Moss, EL Burnham, ... Critical Care Medicine 50 (4), 644-654, 2022 | 12 | 2022 |
| Evaluation of the clinical impact of thromboprophylaxis in patients with COVID-19 following hospital discharge LA Courtney, TC Trujillo, JJ Saseen, G Wright, S Palkimas Annals of Pharmacotherapy 56 (9), 981-987, 2022 | 9 | 2022 |
| Evaluation of safety and efficacy outcomes of direct oral anticoagulants versus warfarin in normal and extreme body weights for the treatment of atrial fibrillation or venous … AR Novak, C Shakowski, TC Trujillo, GC Wright, SW Mueller, TH Kiser Journal of Thrombosis and Thrombolysis 54 (2), 276-286, 2022 | 9 | 2022 |
| Colorado Pulmonary Outcomes Research Group (CPOR). Evaluation of prophylactic heparin dosage strategies and risk factors for venous thromboembolism in the critically ill patient PM Reynolds, ET Van Matre, GC Wright, RB McQueen, EL Burnham, ... Pharmacotherapy 39 (3), 232-241, 2019 | 7 | 2019 |
| Utilization of acute gout prophylaxis in the real world: a retrospective database cohort analysis ML Maes, JJ Saseen, G Wright, LW Claus Clinical Rheumatology 40, 1017-1026, 2021 | 6 | 2021 |
| Economic impact of coverage expansion for non-invasive prenatal testing through a performance-based risk-sharing agreement TAG Quinlan, B Schroeder, S Kwon, JF Barlow, MS Sherman, ... PharmacoEconomics-Open 5, 449-458, 2021 | 5 | 2021 |
| Contraceptive use in women of childbearing ability with rheumatoid arthritis E Ingram, L Claus, J Kolfenbach, G Wright, LM Borgelt JCR: Journal of Clinical Rheumatology 27 (3), 97-101, 2021 | 4 | 2021 |
| Evaluation of Colorado oncology providers on the use of medical marijuana. AE Glode, GC Wright, S Leong Journal of Clinical Oncology 37 (15_suppl), 10511-10511, 2019 | 4 | 2019 |
| Comparison of two different intravenous serotonin antagonists used for chemotherapy-induced nausea and vomiting prophylaxis in patients treated with moderately emetogenic risk … M Gamble, E Carroll, GC Wright, AE Glode Journal of Oncology Pharmacy Practice 26 (8), 1964-1969, 2020 | 3 | 2020 |
| Using Real-World Data to Inform Value-Based Contracts for Cell and Gene Therapies in Medicaid A Zemplenyi, J Leonard, MJ DiStefano, KE Anderson, GC Wright, ... Pharmacoeconomics 42 (3), 319-328, 2024 | 2 | 2024 |
| Association between Substance Misuse and Outcomes in Critically III Patients with Pneumonia PM Reynolds, M Afshar, GC Wright, PM Ho, TH Kiser, PD Sottile, ... Annals of the American Thoracic Society 20 (4), 556-565, 2023 | 2 | 2023 |
| Medications associated with occurrence of urinary tract infections in patients with diabetes, heart failure or both JB Hill, C Fixen, G Wright, JJ Saseen Current Drug Safety 18 (3), 368-373, 2023 | 1 | 2023 |
| Evaluation of an opioid pain teleconsultation service to address the opioid overdose epidemic in Colorado: a Health First Colorado demonstration project HD Anderson, V Patterson, G Wright, JE Rawlings, GD Moore, B Utter, ... Journal of the American Pharmacists Association 63 (1), 301-308, 2023 | 1 | 2023 |
| Emergency contraception in a historic southern city: Mystery caller study in Birmingham, Alabama H Yi, CA Stamm, G Wright, WS Mondie, L Rupp, L Borgelt Contraception 132, 110361, 2024 | | 2024 |
| Evaluating the prescribing and monitoring of medications associated with QTc‐prolongation in the ambulatory care setting RN Lowe, G Wright, L Olivas, C Teel, K Suresh, LB Macke, A Sieja, ... Journal of Evaluation in Clinical Practice 30 (3), 385-392, 2024 | | 2024 |
| Evaluating the Effect of COVID-19 on Outpatient Opioid Utilization Among Health First Colorado Members and a National Non-Medicaid Cohort: An Interrupted Time Series Analysis HD Anderson, VP Patterson, G Wright, JE Rawlings, GD Moore, ... Therapeutics and Clinical Risk Management, 745-753, 2023 | | 2023 |
reynolds, pmUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences在 ucdenver.edu 的电子邮件经过验证
